Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award 2024-12-31 20:00
Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study 2024-12-31 19:10
Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene 2024-12-31 08:00
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports 2024-12-31 04:45
I Peace manufactures 100 lines of GMP iPS Cells cumulatively 2024-12-31 04:24
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference 2024-12-30 23:00
CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel) 2024-12-30 21:50
Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer 2024-12-30 13:28
Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726 2024-12-30 13:00
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging 2024-12-30 06:00
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference 2024-12-27 09:44
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved 2024-12-26 17:09
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design 2024-12-26 11:07
Haikou delivers mix of tradition and cutting-edge industry 2024-12-26 10:07
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting 2024-12-25 15:42
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS 2024-12-24 20:00
Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis 2024-12-23 22:31
Porton Pharma Solutions and Dragon Sail Pharmaceutical Form Strategic Partnership to Build a New Ecosystem for ADC Drug Development, Production, and Supply Chain 2024-12-23 21:00
Kickstart 2025 with Expert Holiday Health Tips 2024-12-23 15:21
Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA 2024-12-23 13:26
1 2 3 4 5 419